LDL-c & PCSK9 inhibition in high CV risk patients

Episodes 1-7 of 7

Challenges for screening and treatment of FH patients in clinical cardiology
Challenges for screening and treatment of FH patients in clinical cardiology
LDL-c Expert Meeting
Challenges for screening and treatment of FH patients in clinical cardiology
Progressive CAD despite low LDL-C, an elusive disease?
Progressive CAD despite low LDL-C, an elusive disease?
LDL-c Expert Meeting
Progressive CAD despite low LDL-C, an elusive disease?
What are the key issues and challenges impacting clinical management with novel therapeutics lowering cholesterol?
What are the key issues and challenges impacting clinical management with novel therapeutics lowering cholesterol?
LDL-c & PCSK9i in Clinical Cardiology
What are the key issues and challenges impacting clinical management with novel therapeutics lowering cholesterol?
Cholesterol guidelines in need of major changes?
Cholesterol guidelines in need of major changes?
LDL-c Expert Meeting
Cholesterol guidelines in need of major changes?
Are very low LDL-c levels safe?
Are very low LDL-c levels safe?
LDL-c Expert Meeting
Are very low LDL-c levels safe?
LDL-c as target in cardiology: The road towards lower targets
LDL-c as target in cardiology: The road towards lower targets
LDL-c Expert Meeting
LDL-c as target in cardiology: The road towards lower targets
How are the guidelines for progressive CAD guiding us in clinical practice?
How are the guidelines for progressive CAD guiding us in clinical practice?
LDL-c Expert Meeting
How are the guidelines for progressive CAD guiding us in clinical practice?

Episodes 1-7 of 7

Title

Share on ReachMD